Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220981232> ?p ?o ?g. }
- W4220981232 abstract "Background: In renal transplantation, chronic transplant dysfunction (CTD) is associated with increased PCSK9 and dyslipidemia. PCSK9 is an enzyme that increases plasma cholesterol levels by downregulating LDLR expression. We recently showed increased PCSK9-syndecan-1 interaction in conditions of proteinuria and renal function loss. Treatment with heparin(oids) might be a therapeutic option to improve dyslipidemia and CTD. We investigated the effects of (non-)anticoagulant heparin(oids) on serum lipids, syndecan-1 and PCSK9 levels, and CTD development. Methods: Kidney allotransplantation was performed from female Dark Agouti to male Wistar Furth recipients. Transplanted rats received daily subcutaneous injections of saline, unfractionated heparin, and RO-heparin or NAc-heparin (2 mg heparin(oid)/kg BW) until sacrifice after 9 weeks of treatment. Results: Saline-treated recipients developed hypertension, proteinuria, and loss of creatinine clearance (all p < 0.05 compared to baseline), along with glomerulosclerosis and arterial neo-intima formation. Saline-treated recipients showed significant increase in plasma triglycerides (p < 0.05), borderline increase in non-HDLc/HDLc (p = 0.051), and ∼10-fold increase in serum syndecan-1 (p < 0.05), without significant increase in serum PCSK9 at 8 weeks compared to baseline. Heparin and non-anticoagulant RO-heparin administration in transplanted rats completely prevented an increase in triglycerides compared to saline-treated recipients at 8 weeks (both p < 0.05). Heparin(oids) treatment did not influence serum total cholesterol (TC), plasma syndecan-1 and PCSK9 levels, creatinine clearance, proteinuria, glomerulosclerosis, and arterial neo-intima formation, 8 weeks after transplantation. Combining all groups, increased syndecan-1 shedding was associated with TC (r = 0.5; p = 0.03) and glomerulosclerosis (r = 0.53; p = 0.021), whereas the non-HDLc/HDLc ratio was associated with the neo-intimal score in the transplanted kidneys (r = 0.65; p < 0.001). Conclusion: Prevention of triglyceridemia by (non-)anticoagulant heparin(oids) neither influenced PCSK9/syndecan-1 nor precluded CTD, which however did associate with the shedding of lipoprotein clearance receptor syndecan-1 and the unfavorable cholesterol profile." @default.
- W4220981232 created "2022-04-03" @default.
- W4220981232 creator A5011477916 @default.
- W4220981232 creator A5031086317 @default.
- W4220981232 creator A5045091059 @default.
- W4220981232 creator A5054611365 @default.
- W4220981232 creator A5070728699 @default.
- W4220981232 creator A5071828751 @default.
- W4220981232 creator A5084282500 @default.
- W4220981232 date "2022-03-07" @default.
- W4220981232 modified "2023-10-14" @default.
- W4220981232 title "Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis" @default.
- W4220981232 cites W128413590 @default.
- W4220981232 cites W1790174844 @default.
- W4220981232 cites W1928881166 @default.
- W4220981232 cites W1966896878 @default.
- W4220981232 cites W1969997949 @default.
- W4220981232 cites W1973614299 @default.
- W4220981232 cites W1982630622 @default.
- W4220981232 cites W1986471883 @default.
- W4220981232 cites W1986962475 @default.
- W4220981232 cites W1996520568 @default.
- W4220981232 cites W1998501202 @default.
- W4220981232 cites W2000340671 @default.
- W4220981232 cites W2009345525 @default.
- W4220981232 cites W2016794737 @default.
- W4220981232 cites W2017592559 @default.
- W4220981232 cites W2020605569 @default.
- W4220981232 cites W2025596599 @default.
- W4220981232 cites W2042792290 @default.
- W4220981232 cites W2049332045 @default.
- W4220981232 cites W2069193872 @default.
- W4220981232 cites W2076059675 @default.
- W4220981232 cites W2079562902 @default.
- W4220981232 cites W2080537677 @default.
- W4220981232 cites W2083930160 @default.
- W4220981232 cites W2097526694 @default.
- W4220981232 cites W2098974363 @default.
- W4220981232 cites W2101016033 @default.
- W4220981232 cites W2105767518 @default.
- W4220981232 cites W2114204825 @default.
- W4220981232 cites W2118170538 @default.
- W4220981232 cites W2118874670 @default.
- W4220981232 cites W2121179180 @default.
- W4220981232 cites W2125556091 @default.
- W4220981232 cites W2131095364 @default.
- W4220981232 cites W2132228009 @default.
- W4220981232 cites W2137907593 @default.
- W4220981232 cites W2150438639 @default.
- W4220981232 cites W2157377815 @default.
- W4220981232 cites W2169093103 @default.
- W4220981232 cites W2275538167 @default.
- W4220981232 cites W2314885458 @default.
- W4220981232 cites W2333413368 @default.
- W4220981232 cites W2337955270 @default.
- W4220981232 cites W2413850691 @default.
- W4220981232 cites W2465758073 @default.
- W4220981232 cites W2574333920 @default.
- W4220981232 cites W2586879243 @default.
- W4220981232 cites W2611725972 @default.
- W4220981232 cites W2621538770 @default.
- W4220981232 cites W2725144244 @default.
- W4220981232 cites W2752803806 @default.
- W4220981232 cites W2770674556 @default.
- W4220981232 cites W2805709976 @default.
- W4220981232 cites W2883373945 @default.
- W4220981232 cites W2896008418 @default.
- W4220981232 cites W2905294564 @default.
- W4220981232 cites W2911569413 @default.
- W4220981232 cites W2945936487 @default.
- W4220981232 cites W2948659925 @default.
- W4220981232 cites W2951842195 @default.
- W4220981232 cites W3002105790 @default.
- W4220981232 cites W3108996899 @default.
- W4220981232 cites W3132222490 @default.
- W4220981232 cites W3136927407 @default.
- W4220981232 cites W3160137119 @default.
- W4220981232 cites W61304035 @default.
- W4220981232 cites W2408974159 @default.
- W4220981232 doi "https://doi.org/10.3389/fcell.2022.798088" @default.
- W4220981232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35345850" @default.
- W4220981232 hasPublicationYear "2022" @default.
- W4220981232 type Work @default.
- W4220981232 citedByCount "0" @default.
- W4220981232 crossrefType "journal-article" @default.
- W4220981232 hasAuthorship W4220981232A5011477916 @default.
- W4220981232 hasAuthorship W4220981232A5031086317 @default.
- W4220981232 hasAuthorship W4220981232A5045091059 @default.
- W4220981232 hasAuthorship W4220981232A5054611365 @default.
- W4220981232 hasAuthorship W4220981232A5070728699 @default.
- W4220981232 hasAuthorship W4220981232A5071828751 @default.
- W4220981232 hasAuthorship W4220981232A5084282500 @default.
- W4220981232 hasBestOaLocation W42209812321 @default.
- W4220981232 hasConcept C126322002 @default.
- W4220981232 hasConcept C126894567 @default.
- W4220981232 hasConcept C134018914 @default.
- W4220981232 hasConcept C159641895 @default.
- W4220981232 hasConcept C2777557582 @default.
- W4220981232 hasConcept C2778096610 @default.
- W4220981232 hasConcept C2780303639 @default.